Provenance Wealth Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.5K Hold
505
﹤0.01% 289
2026
Q1
$24.3K Hold
505
﹤0.01% 258
2025
Q4
$24.5K Hold
505
﹤0.01% 251
2025
Q3
$23.8K Hold
505
﹤0.01% 270
2025
Q2
$24.4K Sell
505
-165
-25% -$8.43K ﹤0.01% 251
2025
Q1
$37.2K Hold
670
0.01% 238
2024
Q4
$32.3K Hold
670
﹤0.01% 245
2024
Q3
$38.6K Hold
670
﹤0.01% 249
2024
Q2
$32.5K Hold
670
﹤0.01% 230
2024
Q1
$32.6K Hold
670
﹤0.01% 243
2023
Q4
$33.3K Buy
670
+561
+515% +$27.4K ﹤0.01% 229
2023
Q3
$5.85K Buy
+109
New +$5.81K ﹤0.01% 265

Other funds holding SNY

Provenance Wealth Advisors's SNY Position: Q2 2026 in Review

Provenance Wealth Advisors held its Sanofi (SNY) position steady in Q2 2026 at 505 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #289.

Provenance Wealth Advisors first reported a position in SNY in Q3 2023 and has held it in 12 quarters since. The position peaked at $38.6K in Q3 2024. 717 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Provenance Wealth Advisors held 505 shares of Sanofi worth $21.5K as of Q2 2026.
  • Provenance Wealth Advisors left its Sanofi share count unchanged in Q2 2026.
  • Sanofi made up ﹤0.01% of Provenance Wealth Advisors's portfolio in Q2 2026, its #289 holding.
  • Provenance Wealth Advisors first reported a position in Sanofi in Q3 2023 and has held it in 12 quarters since.
  • Provenance Wealth Advisors's Sanofi position peaked at $38.6K in Q3 2024.
  • 717 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Provenance Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.